Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexentis TechnologiesNXTS +2.17%37 Earnings Yield (Joel Greenblatt) % is 416.67% as of Jun. 2026. GuruFocus rates NXTS with a GF Score™ of 37/100 and a GF Value™ of $3.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 262 Agriculture companies, Nexentis Technologies ranks worse than 381679.01% on this metric.
Nexentis Technologies's Enterprise Value for the quarter that ended in Jun. 2026 was $-2.31 Mil.
Nexentis Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $-9.74 Mil. Nexentis Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 416.67%.
The historical rank and industry rank for Nexentis Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NXTS'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -83743.5 Med: -12.11 Max: 7143.65
Current: 166.67
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Nexentis Technologies was 7143.65%. The lowest was -83743.50%. And the median was -12.11%.
NXTS's Earnings Yield (Joel Greenblatt) % is not ranked
in the Agriculture industry.
Industry Median: 6.015
vs NXTS: 166.67
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Nexentis Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Nexentis Technologies Earnings Yield (Joel Greenblatt) % Related Terms
Nexentis Technologies Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Nexentis Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Nexentis Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexentis Technologies Earnings Yield (Joel Greenblatt) % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nexentis Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nexentis Technologies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Nexentis Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Nexentis Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.74 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 416.67% mean?
Nexentis Technologies (NXTS) has a Earnings Yield (Joel Greenblatt) % of 416.67% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Nexentis Technologies and its competitors. According to the industry distribution chart, Nexentis Technologies ranks #999999 out of 262 companies in the Agriculture industry.
Is Nexentis Technologies' Earnings Yield (Joel Greenblatt) % too high?
Nexentis Technologies' current Earnings Yield (Joel Greenblatt) % is 416.67%. The Agriculture industry median Earnings Yield (Joel Greenblatt) % is 6.02. Nexentis Technologies' value of 416.67% is 6827.2% above this industry median. Based on the distribution chart, Nexentis Technologies ranks #999999 out of 262 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Nexentis Technologies has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexentis Technologies' Earnings Yield (Joel Greenblatt) % compare to PUBC and ENFY?
According to the Agriculture industry distribution chart, Nexentis Technologies ranks #999999 out of 262 companies for Earnings Yield (Joel Greenblatt) %. This places Nexentis Technologies in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.02. Nexentis Technologies' value of 416.67% is 6827.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for an Agriculture company?
The median Earnings Yield (Joel Greenblatt) % among Agriculture companies is 6.02, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexentis Technologies's current Earnings Yield (Joel Greenblatt) % of 416.67% is 6827.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Nexentis Technologies and its competitors. For the Agriculture industry, the median Earnings Yield (Joel Greenblatt) % is 6.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexentis Technologies's current Earnings Yield (Joel Greenblatt) % is 416.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexentis Technologies stock overvalued right now?
Based on GuruFocus' analysis, Nexentis Technologies (NXTS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.38, compared to a current price of $1.88 — trading 44.4% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 416.67% and 6827.2% above the Agriculture industry median of 6.02. Nexentis Technologies' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Nexentis Technologies (NXTS), the current Earnings Yield (Joel Greenblatt) % is 416.67% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexentis Technologies (NXTS) Overvalued in 2026?
Based on GuruFocus' analysis, Nexentis Technologies stock appears to be undervalued.
The current stock price of $1.88 is trading 44.4% below its estimated GF Value™ of $3.38.
GuruFocus considers Nexentis Technologies to be Possible Value Trap.
Key valuation signals for NXTS:
Earnings Yield (Joel Greenblatt) %: 416.67%
GF Value™: $3.38 vs. price of $1.88 (44.4% below fair value)
Industry Position: 6827.2% above the Agriculture median (#999999 of 262)
No single metric tells the full story. See the NXTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
37GF Score
Get the complete analysis for NXTS
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXTS has been successfully added to your 
